04/12/2024 3:14 PM | scPharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024 11:21 AM | BlackRock Inc. (Filed by) scPharmaceuticals (Subject)
| Form SC 13G/A | |
04/02/2024 3:15 PM | scPharmaceuticals (Issuer) Tucker John H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/24/2024 11:15 PM | scPharmaceuticals (Filer)
| Form EFFECT | |
03/13/2024 3:49 PM | scPharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/13/2024 3:58 PM | scPharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024 3:08 PM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 3:25 PM | 5AM Ventures IV, L.P. (Filed by) scPharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024 5:06 AM | Rubric Capital Management LP (Filed by) scPharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024 5:55 PM | HIRSCHMAN ORIN (Filed by) scPharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024 11:35 AM | Cowen Financial Products LLC (Filed by) scPharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024 7:27 PM | scPharmaceuticals (Issuer) Tucker John H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 7:28 PM | Nokes Rachael (Reporting) scPharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:30 PM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 3:31 PM | scPharmaceuticals (Issuer) Tucker John H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 3:23 PM | scPharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/20/2023 3:10 PM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2023 6:00 AM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 3:29 PM | scPharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023 3:08 PM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |